Skip to Content

Join the 'HIV Infection' group to help and get support from people like you.

HIV Infection News

Related terms: Acquired Immune Deficiency Syndrome, Acquired Immunodeficiency Syndrome (AIDS), Acute HIV Infection, Acute Retroviral Syndrome, AIDS, AIDS-Related Complex, Chronic Symptomatic HIV Infection, HIV Infection, Acute, HIV Seroconversion Syndrome, Human Immunodeficiency Virus Infection, Primary HIV Infection, HIV, ARC, Acquired Immunodeficiency Syndrome, HIV/AIDS

HIV Treatment Protects Uninfected Partner From the Virus

Posted 1 day 14 hours ago by Drugs.com

TUESDAY, July 25, 2017 – HIV treatment prevented transmission of the virus in gay couples when only one partner had the virus, a new study shows. The research included 358 such gay couples in Australia, Brazil and Thailand. The HIV-positive partners received treatment that reduced the amount of virus in the blood to undetectable levels. The participants were followed from 2012 to 2016. During that time, the couples reported nearly 17,000 instances of anal intercourse without a condom. None resulted in HIV transmission, the study authors said. "Undetectable virus level effectively prevents HIV transmission among gay couples," said chief study investigator Andrew Grulich, a professor at the Kirby Institute at the University of New South Wales in Australia. "This is life-changing news for couples of differing HIV status. But it is important that the HIV positive partner is under regular ... Read more

Related support groups: HIV Infection, Tamiflu, Pre-Exposure Prophylaxis, Incivek, Truvada, Baraclude, Victrelis, Oseltamivir, Viread, Kaletra, Tenofovir, Entecavir, Norvir, Lamivudine, Telaprevir, Nevirapine, Boceprevir, Prezista, Reyataz, Abacavir

Bacteria May Explain Why Uncircumcised Face Higher HIV Risk

Posted 1 day 20 hours ago by Drugs.com

TUESDAY, July 25, 2017 – For the first time, bacteria that live under the foreskin of uncircumcised straight men have been linked to a rise in the risk for contracting HIV, new research indicates. Researchers found four specific types of bacteria tied to a higher risk of the AIDS-causing virus. These bacteria are part of the microbiome – a collection of microorganisms found in a particular area – of the area on the penis located under the foreskin. The study of African men revealed that whenever these bacteria increase in quantity by a factor of 10, HIV risk appears to rise by as much as 63 percent. "We found that heterosexual men who carried certain kinds of bacteria on their penises were more likely to get infected by HIV," explained study lead author Dr. Cindy Liu. She's an assistant professor of environmental and occupational health with George Washington University's Milken ... Read more

Related support groups: Bacterial Infection, HIV Infection, Bacterial Skin Infection, Pre-Exposure Prophylaxis, Diagnosis and Investigation

Meds by Monthly Injection Might Revolutionize HIV Care

Posted 2 days 20 hours ago by Drugs.com

MONDAY, July 24, 2017 – Getting a shot of medication to control HIV every month or two instead of having to take pills every day could transform the way the virus is kept at bay. New research suggests that injectable, long-acting antiretroviral therapy for HIV is as safe and effective as oral medications. The injection – given every four or eight weeks – includes the drugs cabotegravir and rilpivirine. "We have made considerable advances in the treatment of HIV over the last several decades," said study lead author Dr. David Margolis. "But for many patients living with HIV, it still remains a challenge to take daily oral medication, either because they are unable to or they choose not to. So it is important to find alternatives." Margolis is medical director of ViiV Healthcare in Research Triangle Park, N.C., the developer of this new approach and the company that funded the trial. ... Read more

Related support groups: HIV Infection, Pre-Exposure Prophylaxis, Incivek, Truvada, Baraclude, Victrelis, Viread, Kaletra, Entecavir, Norvir, Tenofovir, Lamivudine, Telaprevir, Nevirapine, Reyataz, Prezista, Boceprevir, Abacavir, Zidovudine, Tivicay

Cows May Offer Clues to an AIDS Vaccine

Posted 6 days ago by Drugs.com

FRIDAY, July 21, 2017 – Cows already give us milk, meat and leather. Now, researchers say they may also hold the key to an AIDS vaccine. Scientists found it took cows just a few weeks to develop powerful antibodies against HIV, the virus that causes AIDS. This suggests they could move from the farm to the laboratory and play an important role in testing experimental AIDS vaccines, researcher Devin Sok and colleagues said in a new study. "One approach to a preventive HIV vaccine involves trying to elicit broadly neutralizing antibodies in healthy people, but so far the experiments have been unsuccessful, in both human and animal studies," said Sok. He's director of antibody discovery and development at the International AIDS Vaccine Initiative, based in New York City. The team of researchers said it immunized four cows. The scientists got a response from the cows within 35 to 52 days. ... Read more

Related support groups: HIV Infection, Diagnosis and Investigation, Vaccination and Prophlaxis

Wider Access to Meds Cuts Global AIDS Deaths in Half

Posted 7 days ago by Drugs.com

THURSDAY, July 20, 2017 – AIDS-related deaths worldwide have been halved since 2005 as more people were able to get lifesaving drugs, UNAIDS (a United Nations Program) says in a new report. In 2016, 19.5 million (53 percent) of the almost 37 million people living with HIV (the virus that causes AIDS) had access to HIV treatment. AIDS-related deaths fell from 1.9 million in 2005 to 1 million in 2016. If the treatment trend continues, the goal to provide drugs for 30 million HIV patients by 2020 will be achieved, according to the report. "We met the 2015 target of 15 million people on treatment and we are on track to double that number to 30 million and meet the 2020 target," said Michel Sidibe, executive director of UNAIDS. "We will continue to scale up to reach everyone in need and honor our commitment of leaving no one behind," Sidibe said in a program news release. The greatest ... Read more

Related support groups: HIV Infection, Tamiflu, Atripla, Pre-Exposure Prophylaxis, Incivek, Truvada, Stribild, Complera, Baraclude, Victrelis, Oseltamivir, Viread, Kaletra, Tenofovir, Entecavir, Norvir, Lamivudine, Telaprevir, Prezista, Reyataz

Surf's Up! How to Plan for a Safe Beach Vacation

Posted 25 Jun 2017 by Drugs.com

SATURDAY, June 24, 2017 – Heading to the beach this summer? Make safety part of your vacation planning. Sun protection belongs at the top of your packing list. Must-haves include sunscreen, sunglasses, protective clothing and a hat, the U.S. Food and Drug Administration says. Here are some of the agency's other recommendations: Don't use tanning beds to pre-tan before a beach vacation. The lamps emit harmful ultraviolet rays that can damage your skin. Also, be aware that spray tans and bronzers do not protect against UV rays. Make a list of medications you need to take, and get enough to last the trip. Keep your medicines with you when traveling. Also, carry a detailed list of what medicines you take and have your health care provider's contact information in case you need medical care while you're away. If you wear contact lenses, pack enough for the entire vacation. Don't forget to ... Read more

Related support groups: Eye Conditions, Hepatitis C, HIV Infection, Sunburn, Sunscreen, Prevention of Sunburn, Visual Defect/Disturbance, Coppertone, Deeptan

Most U.S. Teens Aren't 'Doing It'

Posted 22 Jun 2017 by Drugs.com

THURSDAY, June 22, 2017 – Sex is everywhere in the media, and so you may be convinced that today's teens are always looking to "hook-up." But new federal research says it's just not so. Instead, the study found that most teenagers in high school aren't sexually active. "The myth is that every kid in high school is having sex, and it's not true," noted Dr. Cora Breuner, a professor of pediatrics at Seattle Children's Hospital, who reviewed the findings. "It's less than half, and it's been less than half for more than 10 years," she said. The study found that only 42 percent of girls and 44 percent of boys aged 15 to 19 reported having sex at least once. And Breuner said that finding is nothing new. Going back to 2002, fewer than half of older teens told researchers that they are sexually active, federal data show. Further, most teens who choose to go all the way wind up losing their ... Read more

Related support groups: Birth Control, Contraception, Plan B, Emergency Contraception, Mirena, Nexplanon, Depo-Provera, Provera, NuvaRing, Sprintec, Implanon, Ortho Tri-Cyclen, Tri-Sprintec, Microgestin Fe 1/20, Yasmin, Plan B One-Step, Loestrin 24 Fe, Ortho Evra, TriNessa, Lutera

Could a Monetary Perk Help Keep HIV Patients on Their Meds?

Posted 22 Jun 2017 by Drugs.com

WEDNESDAY, June 21, 2017 – There are mixed results from a new study on the use of monetary rewards to help boost the odds that HIV-infected patients will enter care, and take their meds as directed. The study, conducted at HIV clinics in New York City and Washington, D.C., found that financial incentives such as gift cards could improve the likelihood that HIV patients would take antiretroviral medications that suppress the AIDS-causing virus. But the effect was modest in patients already receiving care, and the gift cards had little effect on increasing the number of new HIV-positive patients who got treated, the study authors said. Still, lead author Dr. Wafaa El-Sadr called the results "encouraging" and said they "should motivate efforts to pursue the further assessment of using financial incentives in HIV treatment programs and to determine their potential impact when scaled up." ... Read more

Related support groups: Harvoni, HIV Infection, Atripla, Pre-Exposure Prophylaxis, Incivek, Truvada, Epclusa, Triumeq, Stribild, Complera, Zepatier, Genvoya, Baraclude, Victrelis, Viread, Viekira Pak, Kaletra, Norvir, Tenofovir, Entecavir

6 Experts Resign from President's HIV/AIDS Advisory Panel in Protest

Posted 19 Jun 2017 by Drugs.com

Six experts resigned from the Presidential Advisory Council on HIV/AIDS because Donald Trump "simply does not care," one of the members wrote in an op/ed piece in Newsweek. Scott Schoettes, counsel and HIV Project Director at Lambda Legal, and five other members resigned on June 13. The council provides advice, information, and recommendations to the Secretary of Health and Human Services to promote effective treatment, prevention, and an eventual cure for HIV. However, as "advocates for people living with HIV, we have dedicated our lives to combating this disease and no longer feel we can do so effectively within the confines of an advisory body to a president who simply does not care," Schoettes wrote in the article published June 16. "The Trump Administration has no strategy to address the on-going HIV/AIDS epidemic, seeks zero input from experts to formulate HIV policy, and – most ... Read more

Related support groups: HIV Infection, Pre-Exposure Prophylaxis, Truvada, Baraclude, Viread, Entecavir, Tenofovir, Lamivudine, Nevirapine, Epivir, Zidovudine, Hepsera, Abacavir, Telbivudine, Efavirenz, Didanosine, Sustiva, Ziagen, Edurant, Intelence

As U.S. Heroin Use Reaches 20-Year High, Cost to Society Soars

Posted 14 Jun 2017 by Drugs.com

WEDNESDAY, June 14, 2017 – Heroin use cost the United States more than $51 billion in 2015, a new study shows. The financial toll includes heroin-related crime and imprisonment. It also includes treatment for addiction as well as chronic infectious diseases contracted through heroin abuse (such as HIV, hepatitis B and C, and tuberculosis), according to researchers from the University of Illinois at Chicago. The total also includes the cost of treating newborns with heroin-related medical conditions; lost productivity on the job and overdose deaths, the researchers said. "The opioid crisis didn't happen overnight," said study co-author Ruixuan Jiang, a pharmacoeconomist at UIC. In a university news release, she said the number of U.S. heroin users doubled from 2000 to 2013. Study co-author Simon Pickard, a professor of pharmacy systems, has been tracking the rise in heroin use for ... Read more

Related support groups: Opiate Dependence, Opiate Withdrawal, Heroin, HIV Infection, Drug Dependence, Hepatitis B, Tuberculosis, Substance Abuse, Toxic Reactions Incl Drug and Substance Abuse, Substance Abuse - Cocaine

FDA Approves First Generic Truvada for HIV Infection and Pre-Exposure Prophylaxis (PrEP)

Posted 14 Jun 2017 by Drugs.com

June 8, 2017 - The U.S. Food and Drug Administration has approved the first generic version of Truvada for the treatment of HIV-1, in combination with other antiretroviral agents, and for pre-exposure prophylaxis (PrEP) in combination with safer sex practices to prevent sexually-acquired HIV infection in adults at high risk. PrEP may be part of a comprehensive HIV prevention strategy that includes safer sex practices, such as consistent and correct condom use, regular HIV testing and risk reduction counseling. As part of PrEP, HIV-uninfected individuals who are at high risk of sexually acquired HIV infection take antiretroviral medication daily to try to lower their chances of becoming infected with HIV if they are exposed to the virus. The most common side effects reported by HIV-1 infected individuals using emtricitabine and tenofovir disoproxil fumarate in clinical trials included ... Read more

Related support groups: HIV Infection, Pre-Exposure Prophylaxis, Truvada, Emtricitabine/Tenofovir

Merck Receives FDA Approval of Isentress HD (raltegravir), a New Once-Daily Option for the Combination Treatment of HIV-1 Infection in Appropriate Patients

Posted 7 Jun 2017 by Drugs.com

KENILWORTH, N.J.-- May 30, 2017 (BUSINESS WIRE)--Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced that the U.S. Food and Drug Administration (FDA) has approved Isentress HD, a new 1200 mg once-daily dose of the company’s integrase inhibitor, Isentress (raltegravir), to be administered orally as two 600 mg film-coated tablets with or without food, in combination with other antiretroviral agents, for the treatment of HIV-1 infection in adults, and pediatric patients weighing at least 40 kg, who are treatment-naïve or whose virus has been suppressed on an initial regimen of Isentress 400 mg given twice daily. “Isentress has been used as a component of treatment regimens for patients diagnosed with HIV-1 for almost a decade,” said Dr. Michael S. Saag, associate dean for global health, and director of the Center for AIDS Research at the University of Alab ... Read more

Related support groups: HIV Infection, Raltegravir, Isentress

Americans With HIV Staying on Lifesaving Meds Longer

Posted 31 May 2017 by Drugs.com

WEDNESDAY, May 31, 2017 – More Americans with HIV are sticking with medications that turn a fatal disease into a manageable condition, a new study shows. "This represents a lot of people who are not dying and not infecting others," said study corresponding author Ira Wilson, chair of Brown University's Health Services Policy and Practice Department, in Providence, R.I. "These differences represent tremendous, very real benefit," he added in a university news release. While there have been significant increases in how long HIV patients take their medications, many people still stop taking the drugs after a few years, the researchers cautioned. In the study, the researchers analyzed data from nearly 43,600 Medicaid patients in 14 states from 2001 to 2010, and found the length of time patients kept taking antiretroviral medications increased more than 50 percent. In 2001-2003, half of ... Read more

Related support groups: Harvoni, HIV Infection, Atripla, Pre-Exposure Prophylaxis, Incivek, Truvada, Epclusa, Triumeq, Stribild, Complera, Zepatier, Genvoya, Baraclude, Victrelis, Viread, Kaletra, Viekira Pak, Tenofovir, Norvir, Entecavir

Scientists Report Progress on Genetic Test for Anal Cancer

Posted 26 May 2017 by Drugs.com

FRIDAY, May 26, 2017 – A new genetic test may detect anal cancer, a disease that's become more common in women, gay and bisexual men, and people with HIV. "If other studies confirm and build upon these findings, this promising research could be used to develop a less invasive method to help doctors identify people who are at a higher risk of anal cancer and avoid unnecessary procedures for those who are at a lower risk," said Dr. Rachel Orritt, Cancer Research U.K.'s health information officer. In most cases, anal cancer is caused by the human papillomavirus, a virus that causes the majority of cervical cancers. "This study builds on what we already know about the link between changes to cell DNA and cervical cancer, and shows that similar changes to the DNA in anal cells could suggest anal cancer," she said. Diagnosing anal cancer is difficult and tough for patients, the researchers ... Read more

Related support groups: Cancer, HIV Infection, Colorectal Cancer, Anal Fissure and Fistula, Diagnosis and Investigation

Charlie Sheen's 2015 HIV Disclosure Spiked Use of Home Test Kits

Posted 18 May 2017 by Drugs.com

THURSDAY, May 18, 2017 – Soon after actor Charlie Sheen revealed his HIV-positive status back in late 2015, rates of at-home testing for the virus shot up to record levels, a new report shows. The study follows on 2016 research that found the the Internet was abuzz with millions more searches for HIV-related topics after the former "Two and a Half Men" star made the disclosure in November of 2015. In total, all English-language searches about HIV quadrupled beyond the usual number the day after Sheen's announcement, said a team from San Diego State University. Searches for information about HIV symptoms and testing were about six times higher than normal. And their follow-up research has now found that weekly sales of the HIV home-test kit OraQuick nearly doubled in the week after the announcement. "Charlie Sheen's disclosure is potentially the most significant domestic HIV prevention ... Read more

Related support groups: HIV Infection, Valtrex, Acyclovir, Pre-Exposure Prophylaxis, Valacyclovir, Ribavirin, Incivek, Zovirax, Baraclude, Famciclovir, Victrelis, Famvir, Viread, Daklinza, Kaletra, Diagnosis and Investigation, Ganciclovir, Valcyte, Tenofovir, Norvir

Page 1 2 3 ... Next

Ask a Question

Further Information

Related Condition Support Groups

Pre-Exposure Prophylaxis, Viral Infection

Related Drug Support Groups

Atripla, Truvada, Stribild, Triumeq, Complera, Genvoya, Viread, Kaletra, Norvir, view more... immune globulin intravenous, tenofovir, lamivudine, Privigen, Prezista, nevirapine, Combivir, Reyataz, ritonavir, Norvir Soft Gelatin, Carimune, Lexiva, Sandoglobulin, Odefsey, Epivir, abacavir, Tivicay, zidovudine, Epzicom, Sustiva, Trizivir, Octagam, dolutegravir, indinavir, raltegravir, lamivudine / zidovudine, atazanavir, didanosine, Descovy, efavirenz, Agenerase, Ziagen, Prezcobix, darunavir, Viramune, Fuzeon, nelfinavir, abacavir / dolutegravir / lamivudine, Viramune XR, amprenavir, Intelence, Isentress, Carimune NF, Edurant, Retrovir, Telzir, stavudine, Venoglobulin-S 10%, Venoglobulin-S 5%, Dutrebis, Selzentry, Gammagard S / D, Gamimune N 5%, Iveegam En, Panglobulin, Zerit XR, Gammar IV, Gamimune, Gamimune N 10%, Gammaplex, Gammar-P IV, Tybost, Vitekta, Polygam S / D, Evotaz, Crixivan, etravirine, zalcitabine, tipranavir, saquinavir, emtricitabine / lopinavir / ritonavir / tenofovir, emtricitabine / nelfinavir / tenofovir, cobicistat / elvitegravir / emtricitabine / tenofovir, emtricitabine / rilpivirine / tenofovir, rilpivirine, maraviroc, lopinavir / ritonavir, delavirdine, abacavir / lamivudine / zidovudine, abacavir / lamivudine, efavirenz / emtricitabine / tenofovir, emtricitabine, fosamprenavir, enfuvirtide, emtricitabine / tenofovir, elvitegravir, cobicistat, Fortovase, Viracept, Epivir-HBV, Invirase, Zerit, Flebogamma, Hivid, Aptivus, Emtriva, Videx EC, lamivudine / raltegravir, cobicistat / darunavir, atazanavir / cobicistat, cobicistat / elvitegravir / emtricitabine / tenofovir alafenamide, emtricitabine / rilpivirine / tenofovir alafenamide, Videx, Rescriptor, emtricitabine / tenofovir alafenamide, Panglobulin NF